Search - tctmd.com

Displaying 921 - 940 of 1209

Sort: Relevancy | Date

Presentation THT 2023

Cardionomics: Tapping Into the Cardiac Plexus

Presenter: Sitaramesh Emani

March 20, 2023

Presentation THT 2023

Recruitment Strategies for Vulnerable and Marginalized Trial Participants

Presenter: Wayne Batchelor

March 20, 2023

Presentation THT 2023

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Presenter: William Abraham

March 20, 2023

Presentation THT 2023

Pullers: Devices That Reduce Renal Vein Pressure

Presenter: Navin Kapur

March 20, 2023

Presentation THT 2023

Training Investigators to Advance Diversity and Inclusion

Presenter: Mariell Jessup

March 20, 2023

Presentation THT 2023

Pushers: Devices That Increase Renal Arterial Pressure

Presenter: Jennifer Cowger

March 20, 2023

Presentation THT 2023

FDA Introduction

Presenter: Changfu Wu

March 20, 2023

Presentation THT 2023

DHF: Who Is Beyond Medical Therapy and in Need of a Device?

Presenter: Ulrich Jorde

March 20, 2023

Presentation THT 2023

FDA Guidance on Meaningful Representation in Clinical Trials

Presenter: Bram Zuckerman

March 20, 2023

Presentation THT 2023

Devices for ADHF: The DRI2P2S Framework

Presenter: Hannah Rosenblum

March 20, 2023

Presentation THT 2023

Application of Exception from Informed Consent to a Multicenter Cardiogenic Shock Trial

Presenter: Graham Nichol

March 20, 2023

Presentation THT 2023

Now is Not Soon Enough: Why Improving Patient Diversity in HF Trials is a Key Priority

Presenter: Harriette Van Spall

March 20, 2023

Presentation THT 2023

Medical Therapies of DHF and the Concept of "Diuretic Resistance"

Presenter: W. H. Wilson Tang

March 20, 2023

Presentation THT 2023

How Tightly Should Treatment Algorithms Be Prescribed in a Clinical Trial Considering Best-Practices & Escalation of Therapy? What Are The Key Treatment Protocol Elements?

Presenter: Navin Kapur

March 20, 2023

Presentation THT 2023

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

Mystery Case 2

Presenter: Jennifer Ho

March 20, 2023

Presentation THT 2023

FDA Introduction

Presenter: Mauro Moscucci

March 20, 2023

Presentation THT 2023

How Do We Improve Advanced Heart Failure Outcomes in ACHD? ACTION Learning Network

Presenter: Ari Cedars

March 20, 2023

Presentation THT 2023

Mystery Case 1

Presenter: Hannah R. Rosenblum

March 20, 2023

Presentation THT 2023

What's the Status of Advanced Heart Failure Care in ACHD Now? MCS, Listing Status and Outcomes

Presenter: Jonathan Menachem

March 20, 2023

Advertisement

Cardionomics: Tapping Into the Cardiac Plexus

Recruitment Strategies for Vulnerable and Marginalized Trial Participants

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Pullers: Devices That Reduce Renal Vein Pressure

Training Investigators to Advance Diversity and Inclusion

Pushers: Devices That Increase Renal Arterial Pressure

FDA Introduction

DHF: Who Is Beyond Medical Therapy and in Need of a Device?

FDA Guidance on Meaningful Representation in Clinical Trials

Devices for ADHF: The DRI2P2S Framework

Application of Exception from Informed Consent to a Multicenter Cardiogenic Shock Trial

Now is Not Soon Enough: Why Improving Patient Diversity in HF Trials is a Key Priority

Medical Therapies of DHF and the Concept of "Diuretic Resistance"

How Tightly Should Treatment Algorithms Be Prescribed in a Clinical Trial Considering Best-Practices & Escalation of Therapy? What Are The Key Treatment Protocol Elements?

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Mystery Case 2

FDA Introduction

How Do We Improve Advanced Heart Failure Outcomes in ACHD? ACTION Learning Network

Mystery Case 1

What's the Status of Advanced Heart Failure Care in ACHD Now? MCS, Listing Status and Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content